FLT3 and acute myeloid leukemia: Adults with newly diagnosed AML; FLT3 mutation‐positive; in combination with standard daunorubicin and cytarabine induction and high‐dose cytarabine consolidation chemotherapy, and for patients in complete response, followed by single‐agent maintenance therapy